Press Contact

If you would like to find out more about Abiomed® and the Impella® heart pumps, or if you have any questions, please do not hesitate to contact us.

Contact

Dr. Sebastian Heindrichs

Associate Director European Communications
ABIOMED Europe GmbH
Neuenhofer Weg 3 | 52074 Aachen,  Germany
E-Mail: sheindrichs(at)abiomed.com
Phone: +49 (0)151 7447 2278

Press Releases

July 30, 2020

Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump

https://www.businesswire.com/news/home/20200730005307/en/Large-Multi-Center-Study-Japan-Finds-High-Survival
PDF Download


July 1, 2020

Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist

https://www.businesswire.com/news/home/20200701005293/en/Study-Finds-84-Survival-Rate-Patients-Cardiogenic
PDF Download


June 16, 2020

Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes

https://www.businesswire.com/news/home/20200616005314/en/Abiomed-Launches-Virtual-Physician-Education-Program-CAMP
PDF Download


June 5, 2020

FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump

https://www.businesswire.com/news/home/20200605005049/en/FDA-Approves-Abiomed%E2%80%99s-First-in-Human-Trial-Impella-ECP
PDF Download


May 19, 2020

PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Associated with Lower Mortality Compared to Bailout PCI

https://www.businesswire.com/news/home/20200519005627/en/PROTECT-III-Study-Shows-Placing-Impella-Prior
PDF Download


April 29, 2020

Abiomed Expands Product Portfolio with Acquisition of Cardiopulmonary Support Technology (ECMO) to Improve Outcomes for Patients

https://www.businesswire.com/news/home/20200429005975/en/Abiomed-Expands-Product-Portfolio-Acquisition-Cardiopulmonary-Support
PDF Download


May 21, 2019

National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery

PDF Download


April 4, 2019

Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval

PDF Download


DE / EN